Get started
JOHNSON & JOHNSONJOHNSON & JOHNSONJOHNSON & JOHNSON

JOHNSON & JOHNSON

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

JNJ chart

What's happening today with JOHNSON & JOHNSON

  • •Johnson & Johnson won a trial against a Florida woman's claim that its baby powder caused her cancer, with the jury concluding that talc is safe and does not cause cancer.
What else is happeningWhat else is happening

Key stats

Market capitalization
‪318.13 B‬CHF
Dividend yield (indicated)
3.43%
Price to earnings Ratio (TTM)
26.66
Basic EPS (TTM)
7.09CHF
Net income
‪11.93 B‬CHF
Revenue
‪71.69 B‬CHF
Shares float
‪2.41 B‬
Beta (1Y)
0.57

About JOHNSON & JOHNSON

Sector
Health Technology
CEO
Joaquin Duato
Headquarters
New Brunswick
Website
jnj.com
Employees (FY)
‪131.9 K‬
Founded
1887
ISIN
US4781601046
FIGI
BBG002JV1FS1
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where JNJ is featured.

See all sparks 

Frequently Asked Questions

The current price of JNJ is 135.40 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange JOHNSON & JOHNSON stocks are traded under the ticker JNJ.
JOHNSON & JOHNSON is going to release the next earnings report on Jul 16, 2024. Keep track of upcoming events with our Earnings Calendar.
JNJ stock is 0% volatile and has beta coefficient of 0.57. Check out the list of the most volatile stocks — is JOHNSON & JOHNSON there?
One year price forecast for JOHNSON & JOHNSON has a max estimate of 196.00 CHF and a min estimate of 141.30 CHF.
JNJ earnings for the last quarter are 1.93 CHF whereas the estimation was 1.92 CHF which accounts for 0.40% surprise. Estimated earnings for the next quarter are 2.40 CHF. See more details about JOHNSON & JOHNSON earnings.
JOHNSON & JOHNSON revenue for the last quarter amounts to ‪18.01 B‬ CHF despite the estimated figure of ‪17.70 B‬ CHF. In the next quarter revenue is expected to reach ‪19.31 B‬ CHF.
Yes, you can track JOHNSON & JOHNSON financials in yearly and quarterly reports right on TradingView.
JNJ net income for the last quarter is ‪4.83 B‬ CHF, while the quarter before that showed ‪3.41 B‬ CHF of net income which accounts for 41.68% change. Track more JOHNSON & JOHNSON financial stats to get the full picture.
Today JOHNSON & JOHNSON has the market capitalization of ‪318.03 B‬, it has increased by 0.80% over the last week.
Yes, JNJ dividends are paid quarterly. The last dividend per share was 1.05 CHF. As of today, Dividend Yield (TTM)% is 3.29%. Tracking JOHNSON & JOHNSON dividends might help you take more informed decisions.
JOHNSON & JOHNSON dividend yield was 3.00% in 2023, and payout ratio reached 84.93%. The year before the numbers were 2.52% and 66.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, JNJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JOHNSON & JOHNSON stock right from TradingView charts — choose your broker and connect to your account.
JNJ reached its all-time high on Nov 20, 2018 with the price of 147.24 CHF, and its all-time low was 62.25 CHF and was reached on Oct 10, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪131.90 K‬ employees. See our rating of the largest employees — is JOHNSON & JOHNSON on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JOHNSON & JOHNSON technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JOHNSON & JOHNSON stock shows the buy signal. See more of JOHNSON & JOHNSON technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on JOHNSON & JOHNSON future price: according to them, JNJ price has a max estimate of 196.00 CHF and a min estimate of 141.30 CHF. Read a more detailed JOHNSON & JOHNSON forecast: see what analysts think of JOHNSON & JOHNSON and suggest that you do with its stocks.